Helen C. Adams - Dec 15, 2021 Form 3 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
Director
Signature
/s/ Ilya Rachman as Attorney-In-Fact for Helen C. Adams
Stock symbol
IMMX
Transactions as of
Dec 15, 2021
Transactions value $
$0
Form type
3
Date filed
12/15/2021, 08:03 PM
Previous filing
Nov 16, 2021
Next filing
May 20, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IMMX Options (right to purchase) Dec 15, 2021 Common stock 37.5K $1.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 18, 2021, the Registrant issued the Reporting Person options to purchase up to 37,500 shares of the Registrant's common stock (the "Options"). The Options vest in 48 monthly installments with the first installment vesting on June 18, 2021, subject to the Reporting Person's continued service with the Registrant.

Remarks:

Exhibit List: Exhibit 24.1 - Powers of Attorney